|
Eurofins is an international group of laboratories headquartered in Luxembourg, providing testing and support services to the pharmaceutical, food, environmental and consumer products industries〔 (Le réseau, botte secrète d'Eurofins ), L'Usine nouvelle n° 2965, 26.05.2005〕〔 (Eurofins. Der Testsieger. Warum der Labormulti von Skandalen in aller Welt und neuen EU-Verordnungen profitiert ), Focus, 15.10.2008〕 and to governments. Eurofins employs more than 20,000 employees across around 200 sites in 38 countries and has about EUR 1.4 billion annual revenues (2014). The Eurofins Group offers a portfolio of over 100,000 reliable analytical methods for characterising the safety, identity, purity, composition, authenticity and origin of products and biological substances. Through research and development, in-licensing and acquisitions, the Group draws on the latest developments in the field of biotechnology and analytical sciences. Eurofins pursued an aggressive strategy of expansion, buying more than eighty competitors worldwide since it was founded. Notable examples include the acquisition in 2005 of the German company MWG-Biotech and in 2011 of the US company Lancaster Laboratories, the latter for 150 million euros.〔 (Le monde entier s’arrache "les Experts" d’Eurofins ), Capital, 01/12/2011〕 ==Recent news== In May 2015, Eurofins acquired QC Laboratories in the US and Experchems in Canada as part of its American expansion strategy. In June 2015, Eurofins announces the acquisition of Biomnis in France for 220 million euros.〔http://www.eurofins.com/en/media-centre/press-releases/2015-06-22.aspx〕 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Eurofins Scientific」の詳細全文を読む スポンサード リンク
|